Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK 2248761

Known as: GSK-2248761, GSK2248761 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The CNS disposition and metabolism of Fosdevirine (FDV), an HIV non-nucleoside reverse transcriptase inhibitor, was investigated… Expand
Is this relevant?
2013
2013
BACKGROUND Fosdevirine (GSK2248761) is a non-nucleoside reverse transcriptase inhibitor with HIV-1 activity against common… Expand
  • figure 1
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
2012
2012
GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with activity… Expand
Is this relevant?
2012
2012
AIM To evaluate potential drug interactions with antiretroviral therapies or supportive therapies for use in conjunction with the… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Review
2010
Review
2010
Antiretroviral drug resistance is one of the complications of highly active antiretroviral therapy (HAART). Second-generation non… Expand
Is this relevant?